日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Germline BRCA1/2 Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in France

法国一项基于大型临床队列的转移性乳腺癌患者研究发现,BRCA1/2基因突变存在于多个生殖系中。

Meynard, Guillaume; Pereira, Victor; Paget-Bailly, Sophie; Klajer, Elodie; Mansi, Laura; Chaigneau, Loïc; Meneveau, Nathalie; Paillard, Marie Justine; Bazan, Fernando; Dobi, Erion; Villanueva, Cristian; Selmani, Zohair; Viot, Julien; Dalens, Lorraine; Goujon, Morgan; Collonge-Rame, Marie-Agnès; Populaire, Céline; Meurisse, Aurélia; Pivot, Xavier; Curtit, Elsa

Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy

监督式间歇运动计划对接受化疗的乳腺癌患者失眠的影响

Drozd, Chloé; Curtit, Elsa; Jacquinot, Quentin; Roux, Pauline; Paget-Bailly, Sophie; Gillet, Valérie; Meneveau, Nathalie; Mougin, Fabienne

Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption

探索 ESR1 突变在转移性激素受体阳性乳腺癌 T 细胞免疫监视中断中的作用

Morgane Lopez, Laurie Spehner, Fabrice André, Julien Viot, Evan Seffar, Amélie Marguier, Elsa Curtit, Guillaume Meynard, Erion Dobi, Sylvain Ladoire, Romain Boidot, Romain Loyon, Valentin Derangere, François-Clément Bidard, Christophe Borg, Laura Mansi #, Marie Kroemer #4

Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors

依维莫司治疗激素受体阳性、HER2阴性、转移性乳腺癌且既往接受过CDK4/6抑制剂治疗的患者的疗效

Dutheil, Justine; Pereira, Victor; Boisson, Cyril; Mansi, Laura; Paillard, Marie-Justine; Bazan, Fernando; Chaigneau, Loic; Dobi, Erion; Viot, Julien; Meynard, Guillaume; Goujon, Morgan; Dalens, Lorraine; Dubourd, Clément; Marchi, Sophie; Meneveau, Nathalie; Vernerey, Dewi; Adotévi, Olivier; Meurisse, Aurélia; Curtit, Elsa

Real-World Evidence of Long-Term Disease Control in HER2-Positive Metastatic Breast Cancer Patients Treated with a First-Line Combination of Trastuzumab and/or Pertuzumab Plus Chemotherapy

真实世界证据表明,一线曲妥珠单抗和/或帕妥珠单抗联合化疗可有效控制HER2阳性转移性乳腺癌患者的长期疾病进展

Chaigneau, Loïc; Lapp, Eva; Jai, Taha; Dobi, Erion; Martin, Berenger; Curtit, Elsa; Nerich, Virginie

Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study)

乳腺癌患者区域淋巴结复发的回顾性综合分析(REASON 研究)

Liapi, Aikaterini; Aedo-Lopez, Veronica; Jeanneret-Sozzi, Wendy; Stravodimou, Athina; Prior, John O; Lalonde, Marie Nicod; Treboux, Assia Ifticene; Lelievre, Loic; Kandalaft, Lana; Rossier, Laetitia; Goupil, Audrey; Bergomi, Marzio; Rivals, Jean-Paul; Brouland, Jean-Philippe; Curtit, Elsa; Meuwly, Jean-Yves; Zaman, Khalil

Postcancer rehabilitation: multidisciplinary exercise - programme organisation and feasibility

癌症后康复:多学科运动——方案组织与可行性

Drozd, Chloé; Jacquinot, Quentin; Paget-Bailly, Sophie; Mansi, Laura; Paillard, Marie-Justine; Bazan, Fernando; Chaigneau, Loic; Dobi, Erion; Viot, Julien; Meynard, Guillaume; Goujon, Morgan; Dalens, Lorraine; Pereira, Victor; Robin, Edgar; Farret, Jean; Gagnepain, Carole; Simon, Ophélie; Fagnoni-Legat, Christine; Mougin, Fabienne; Meneveau, Nathalie; Curtit, Elsa

A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study

一项随机试验旨在评估监督式运动计划对接受化疗的非转移性乳腺癌患者失眠的影响:FATSOMCAN 研究设计

Drozd, Chloé; Curtit, Elsa; Jacquinot, Quentin; Marquine, Charlène; Mansi, Laura; Chaigneau, Loïc; Dobi, Erion; Viot, Julien; Meynard, Guillaume; Paillard, Marie-Justine; Goujon, Morgan; Roux, Pauline; Vernerey, Dewi; Gillet, Valérie; Bourdin, Hubert; Galli, Silvio; Meneveau, Nathalie; Mougin, Fabienne

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis

利用基因组特征指导法国早期乳腺癌患者辅助化疗决策:一项成本效益分析

Curtit, Elsa; Bellanger, Martine Marie; Nerich, Virginie; Hequet, Delphine; Frenel, Jean-Sebastien; Cristeau, Olivier; Rouzier, Roman

Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial

癌症患者 COVID-19 mRNA 疫苗的预测性生物标志物和特异性免疫反应:CACOV-VAC 试验的前瞻性结果

Laurie Spehner, Emeline Orillard, Antoine Falcoz, Quentin Lepiller, Adeline Bouard, Hamadi Almotlak, Stefano Kim, Elsa Curtit, Guillaume Meynard, Marine Jary, Charlee Nardin, Kamal Asgarov, Syrine Abdeljaoued, Ugo Chartral, Virginie Mougey, Myriam Ben Khelil, Morgane Lopez, Romain Loyon, Dewi Verner